On June 22, China IPO learned that Mega Genomics (06667.HK) was officially listed on Hong Kong Exchanges and Clearing Limited today.

In early trading, Mega Genomics opened 8.22% higher at HK$19.48, and rose to 16.39% during the session. As of press time, it rose 5.22% to HK$18.94, with the latest market value of HK$4.531 billion.

According to the results of the previous IPO placement, Mega Genomics was offered at HK$18 per share, with 200 shares per lot, and issued 11,961,800 shares globally, including 1,196,200 shares in Hong Kong and 10,765,600 shares internationally.

Mega Genomics is a genetic testing platform company, focusing on consumer-grade genetic testing and cancer screening services. As of December 31, 2021, the company has performed more than 12 million genetic tests since its inception in 2016, with an average of more than 246,000 tests per month in 2020.